Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)

40 mg/m\^2 by vein over 60 minutes on Day -5 through Day -2.

Busulfan administered at the dose calculated to achieve an area under curve (AUC) of 4000 µMol-min + 12% based on the pharmacokinetic studies (days -5, -4, -3, and -2).

2.5 mg/kg by vein over about 4-6 hours on Day -3 through Day -1.

Start cycles of 32 mg/m\^2 daily as an injection under the skin once a day over 5 days in a row, starting about 5 weeks after the transplant. This may be repeated once a month for up to 4 months after the transplant.

Stem cell infusion on day 0 administered by vein after collected from donor.